Ipledgeprogram
AEO Score: 3/10
About
The iPLEDGE PROGRAM REMS (Risk Evaluation and Mitigation Strategy) The iPLEDGE PROGRAM REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure. The REMS is required by the U.S. Food and Drug Administration (FDA) to ensure the benefits of isotretinoin outweigh its risks.
Details
Category: Professional Services
ipledgeprogram.comAI Visibility Breakdown
1
Structured Data
4
Content Structure
5
Entity Clarity
2
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim this page to light it up, add your full profile, and make sure AI engines cite you correctly.
Claim your page freePowered by Engagemii - AI Brand Discovery and AEO Platform
Updated May 2026